Table 2.

Characteristics of KIR ligand absence in transplant patients




Recipients with ligand absent, no. (%)*
HLA-C group 1 (HLA-CAsn80) absent for donor KIR2DL2/3   27 (24.1)  
HLA-C group 2 (HLA-CLys80) absent for donor KIR2DL1   31 (27.7)  
HLA-Bw4 absent for donor KIR3DL1   19 (17.0)  
HLA-Bw4 and HLA-C absent for donor KIR
 
35 (31.3)
 



Recipients with ligand absent, no. (%)*
HLA-C group 1 (HLA-CAsn80) absent for donor KIR2DL2/3   27 (24.1)  
HLA-C group 2 (HLA-CLys80) absent for donor KIR2DL1   31 (27.7)  
HLA-Bw4 absent for donor KIR3DL1   19 (17.0)  
HLA-Bw4 and HLA-C absent for donor KIR
 
35 (31.3)
 
*

n = 112, 62.9% of the 178 patients in the study.

or Create an Account

Close Modal
Close Modal